Tm Bioscience acquires key sepsis biomarkers from Sirius Genomics
Tm to develop companion test for drugs used to treat severe sepsis
Tm Bioscience Corporation announced it has signed an agreement with Sirius Genomics for an exclusive commercial license to patents from Sirius for specific biomarkers related to drugs used to treat severe sepsis including vasopressin. Tm Bioscience will incorporate these markers into a diagnostic for use by critical care physicians which it expects to launch in the second half of 2007.
"By applying the genetic discoveries made by Sirius Genomics, we hope to develop an innovative genetic test that could be used to identify patients who are more likely to respond well to the two main drugs used to treat severe sepsis. Such tests could help save lives," said Greg Hines, President and CEO of Tm Bioscience.
The agreement covers a series of possible mutations that can occur in the genes associated with two proteins, protein C and arginine vasopressin. Under the terms of the agreement, Tm Bioscience will provide an upfront payment of $4 million which will be provided to Sirius in two equal installments in the second and third quarters of 2006. These upfronts will be repaid from net earnings on commercial sales of the severe sepsis test, with the remaining earnings shared equally by Sirius and Tm over the term of the agreement.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
List_of_subjects_in_Gray's_Anatomy:_IX._Neurology
Engineered protein-like molecule protects cells against HIV infection

Membrane vesicles released by bacteria may play different roles during infection
Illumina and Oxford Nanopore Enter into Broad Commercialization Agreement - Single-Molecule DNA Sequencing System Promises Dramatic Improvement in Cost, Speed, Versatility, and Simplicity of Sequencing
Deutsche_Medizinische_Wochenschrift

Signal blocks stem cell division in the geriatric brain

Proven for the First Time: The Microbiome of Fruit and Vegetables Positively Influences Diversity in the Gut - Bacterial diversity in the gut plays an important role in human health
Alfred_P._Sloan_Foundation

How autonomous AI agents will change cancer research - More time for the essential
Category:Xanthomonadales
